Systematic review on cost-effectiveness of public health interventions for primary HIV-prevention programs.
Rating of publications using the guidelines for economic studies in medicine of the British Medical Journal Economic Evaluation Working Party.
Studies with defined nondrug intervention, defined study population, identifiable method of analysis and at least one endpoint for evaluation of intervention were included.
One publication could consist of more than one study.
Methods to generate effectiveness data, inclusion of human costs and kind of outcome parameters for economic evaluation were documented.
To avoid bias in performing the review, the British Medical Journal guidelines were applied.
Cost-effectiveness data were reviewed according to outcome parameters used in economic evaluation.
Forty studies were identified in 34 publications, 30/40 from the United States and 22 supported by public funding ; only five studies were directed to men who have sex with men, intravenous drug users and persons with HIV-infected partners.
Screening programs and counseling with testing accounted for 30/40 studies.
Complete research question (intervention and outcome) was presented in 29/40 studies (72.5%). Thirty-four studies were conducted from the societal perspective and the viewpoint was clearly stated in 31/40 studies. (...)
Mots-clés Pascal : SIDA, Virose, Infection, Programme sanitaire, Prévention, Analyse coût efficacité, Pays industrialisé, Revue bibliographique, Immunopathologie, Immunodéficit, Economie santé
Mots-clés Pascal anglais : AIDS, Viral disease, Infection, Sanitary program, Prevention, Cost efficiency analysis, Industrialized country, Bibliographic review, Immunopathology, Immune deficiency, Health economy
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0511226
Code Inist : 002B05C02D. Création : 23/03/1999.